• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用多粘菌素B固定化纤维柱进行长时间直接血液灌流可使感染性休克患者的循环持续稳定:一项回顾性前后观察研究。

Prolonged direct hemoperfusion using a polymyxin B immobilized fiber cartridge provides sustained circulatory stabilization in patients with septic shock: a retrospective observational before-after study.

作者信息

Miyamoto Kyohei, Kawazoe Yu, Kato Seiya

机构信息

Department of Emergency and Critical Care Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama City, Wakayama Japan.

Division of Emergency and Critical Care Medicine, Tohoku University Hospital Emergency Center, 1-1, Seiryo-machi, Aoba-ku, Sendai City, Miyagi Japan.

出版信息

J Intensive Care. 2017 Feb 20;5:19. doi: 10.1186/s40560-017-0214-3. eCollection 2017.

DOI:10.1186/s40560-017-0214-3
PMID:28239476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5319036/
Abstract

BACKGROUND

Direct hemoperfusion therapy with polymyxin B immobilized fiber cartridges (PMX-DHP) is widely used for septic shock in Japan and parts of Europe. Although this treatment is usually administered for 2 h, the optimal duration has not been established.

METHODS

This retrospective study compared the effects of prolonged and conventional PMX-DHP durations (2 and 12 h, respectively) for septic shock. Between October 2013 and March 2015, 18 patients underwent conventional PMX-DHP, and between April 2015 and May 2016, 18 patients underwent prolonged PMX-DHP. The primary outcome was the vasopressor dependency index during the 12 h after starting the first PMX-DHP session. The vasopressor dependency index was calculated as (inotropic score)/(mean blood pressure).

RESULTS

The patients' characteristics were almost similar in the conventional and prolonged PMX-DHP groups. The major site of infection was the abdomen in both groups (61 and 72%, respectively). The conventional PMX-DHP group had mean blood pressure values of 68.4 ± 8.9 mmHg and 78.2 ± 16.9 mmHg at 0 and 12 h after starting PMX-DHP ( = 0.13). The prolonged PMX-DHP group had mean blood pressure values of 70.3 ± 15.7 mmHg and 87.7 ± 16.9 mmHg at 0 and 12 h after starting PMX-DHP ( = 0.004). The conventional PMX-DHP group had vasopressor dependency index values of 0.52 ± 0.29 and 0.39 ± 0.25 at 0 and 12 h after starting PMX-DHP ( = 0.29). The prolonged PMX-DHP group had vasopressor dependency index values of 0.50 ± 0.26 and 0.28 ± 0.18 at 0 and 12 h after starting PMX-DHP ( = 0.01). Hospital mortality was similar in both groups (8/18 [44%] and 8/18 [44%]).

CONCLUSIONS

These findings suggest that prolonged PMX-DHP provides more sustained circulatory stabilization compared to conventional PMX-DHP. However, our study failed to detect any improvement in mortality. Well-designed prospective trials are needed to examine the clinical outcomes of prolonged PMX-DHP and to identify the optimal duration of PMX-DHP.

摘要

背景

使用多粘菌素B固定化纤维柱的直接血液灌流疗法(PMX-DHP)在日本和欧洲部分地区被广泛用于治疗感染性休克。尽管这种治疗通常进行2小时,但最佳治疗时长尚未确定。

方法

这项回顾性研究比较了延长PMX-DHP时长(12小时)和传统时长(2小时)治疗感染性休克的效果。2013年10月至2015年3月期间,18例患者接受了传统PMX-DHP治疗;2015年4月至2016年5月期间,18例患者接受了延长PMX-DHP治疗。主要结局指标是首次进行PMX-DHP治疗后12小时内的血管升压药依赖指数。血管升压药依赖指数的计算方法为(肌力评分)/(平均血压)。

结果

传统PMX-DHP组和延长PMX-DHP组患者的特征几乎相似。两组感染的主要部位均为腹部(分别为61%和72%)。传统PMX-DHP组在开始PMX-DHP治疗后0小时和12小时的平均血压值分别为68.4±8.9 mmHg和78.2±16.9 mmHg(P = 0.13)。延长PMX-DHP组在开始PMX-DHP治疗后0小时和12小时的平均血压值分别为70.3±15.7 mmHg和87.7±16.9 mmHg(P = 0.004)。传统PMX-DHP组在开始PMX-DHP治疗后0小时和12小时的血管升压药依赖指数值分别为0.52±0.29和0.39±0.25(P = 0.29)。延长PMX-DHP组在开始PMX-DHP治疗后0小时和12小时的血管升压药依赖指数值分别为0.50±0.26和0.28±0.18(P = 0.01)。两组的医院死亡率相似(分别为8/18 [44%]和8/18 [44%])。

结论

这些结果表明,与传统PMX-DHP相比,延长PMX-DHP能使循环更持久地稳定。然而,我们的研究未能发现死亡率有任何改善。需要设计完善的前瞻性试验来研究延长PMX-DHP的临床结局,并确定PMX-DHP的最佳治疗时长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d5a/5319036/c98062e66627/40560_2017_214_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d5a/5319036/c98062e66627/40560_2017_214_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d5a/5319036/c98062e66627/40560_2017_214_Fig1_HTML.jpg

相似文献

1
Prolonged direct hemoperfusion using a polymyxin B immobilized fiber cartridge provides sustained circulatory stabilization in patients with septic shock: a retrospective observational before-after study.使用多粘菌素B固定化纤维柱进行长时间直接血液灌流可使感染性休克患者的循环持续稳定:一项回顾性前后观察研究。
J Intensive Care. 2017 Feb 20;5:19. doi: 10.1186/s40560-017-0214-3. eCollection 2017.
2
Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study.延长多黏菌素 B 免疫吸附纤维柱直接血液灌流对脓毒症患者血流动力学、血管活性物质需求和肺氧合的影响:一项观察性研究。
Blood Purif. 2022;51(1):62-69. doi: 10.1159/000515685. Epub 2021 Apr 28.
3
Initial central venous pressure could be a prognostic marker for hemodynamic improvement of polymyxin B direct hemoperfusion: a retrospective cohort study.初始中心静脉压可能是多粘菌素B直接血液灌流血流动力学改善的预后标志物:一项回顾性队列研究
J Intensive Care. 2016 Oct 10;4:64. doi: 10.1186/s40560-016-0186-8. eCollection 2016.
4
Prognostic factors in patients with septic shock in digestive surgery who have undergone direct hemoperfusion with polymyxin B-immobilized fibers: a retrospective observational study.聚砜固定化纤维直接血液灌流治疗消化外科脓毒性休克患者的预后因素:一项回顾性观察研究。
J Intensive Care. 2015 Mar 13;3:13. doi: 10.1186/s40560-015-0078-3. eCollection 2015.
5
Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.多黏菌素B固定化纤维柱直接血液灌流治疗重症脓毒症和感染性休克更长疗程的临床效果
Ther Apher Dial. 2015 Aug;19(4):316-23. doi: 10.1111/1744-9987.12339.
6
pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock.首次使用多粘菌素B固定化纤维进行直接血液灌流后的pH值可预测脓毒症和脓毒性休克患者的死亡率。
Clin Exp Nephrol. 2018 Oct;22(5):1167-1173. doi: 10.1007/s10157-018-1548-4. Epub 2018 Feb 24.
7
Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.早期使用多粘菌素B固定化柱进行直接血液灌流与改善感染性休克患者的血流动力学紊乱及降低死亡率相关。
J Artif Organs. 2017 Mar;20(1):71-75. doi: 10.1007/s10047-016-0922-9. Epub 2016 Jul 28.
8
Clinical Effects of Polymyxin B Hemoperfusion in Patients With Septic Shock Caused by Urinary Tract Infection.多黏菌素B血液灌流对尿路感染所致脓毒性休克患者的临床疗效
Ther Apher Dial. 2019 Feb;23(1):80-85. doi: 10.1111/1744-9987.12746. Epub 2018 Sep 12.
9
The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock.高动力循环的严重程度可能预示着革兰氏阴性脓毒性休克患者使用固定化多粘菌素B纤维吸附柱进行直接血液灌流的效果。
Ther Apher. 2001 Feb;5(1):25-30. doi: 10.1046/j.1526-0968.2001.005001025.x.
10
Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.使用固定多粘菌素B的纤维吸附柱进行直接血液灌流去除内毒素可改善感染性休克患者的全身循环障碍。
Am J Kidney Dis. 2002 May;39(5):937-47. doi: 10.1053/ajkd.2002.32767.

引用本文的文献

1
Time to administer polymyxin B hemoperfusion and hemodynamics in patients with septic shock requiring high-dose norepinephrine: a predetermined analysis of a prospective cohort study.脓毒性休克患者在需要大剂量去甲肾上腺素治疗时进行多粘菌素B血液灌流的时机及血流动力学:一项前瞻性队列研究的预设分析
Crit Care. 2025 May 9;29(1):187. doi: 10.1186/s13054-025-05422-7.
2
Effects of Early Initiation of Polymyxin B Hemoperfusion Therapy in Patients with Cancer with Refractory Septic Shock.早期启动多粘菌素B血液灌流疗法对癌症合并难治性感染性休克患者的影响。
J Clin Med. 2024 Feb 9;13(4):1009. doi: 10.3390/jcm13041009.
3
The Rationale and Current Status of Endotoxin Adsorption in the Treatment of Septic Shock.

本文引用的文献

1
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).制定脓毒性休克的新定义并评估新的临床标准:用于第三次脓毒症和脓毒性休克国际共识定义(Sepsis-3)。
JAMA. 2016 Feb 23;315(8):775-87. doi: 10.1001/jama.2016.0289.
2
Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.多黏菌素B固定化纤维柱直接血液灌流治疗重症脓毒症和感染性休克更长疗程的临床效果
Ther Apher Dial. 2015 Aug;19(4):316-23. doi: 10.1111/1744-9987.12339.
3
Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.
内毒素吸附在脓毒性休克治疗中的原理及现状
J Clin Med. 2022 Jan 26;11(3):619. doi: 10.3390/jcm11030619.
4
Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms.多粘菌素B对碳青霉烯类耐药菌感染患者的临床疗效
Infect Drug Resist. 2021 May 28;14:1979-1988. doi: 10.2147/IDR.S312708. eCollection 2021.
5
Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock.关于多粘菌素B固定化纤维柱直接血液灌流治疗感染性休克的最新信息。
Acute Crit Care. 2021 May;36(2):85-91. doi: 10.4266/acc.2021.00150. Epub 2021 Apr 4.
6
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.COVID-19 患者采用多粘菌素 B 固定化聚苯乙烯柱进行直接血液灌流。
J Clin Apher. 2021 Jun;36(3):313-321. doi: 10.1002/jca.21861. Epub 2020 Dec 15.
多粘菌素B血液灌流在腹膜炎所致感染性休克患者中的早期应用:一项多中心随机对照试验
Intensive Care Med. 2015 Jun;41(6):975-84. doi: 10.1007/s00134-015-3751-z. Epub 2015 Apr 11.
4
The Japanese guidelines for the management of sepsis.日本脓毒症管理指南。
J Intensive Care. 2014 Oct 28;2(1):55. doi: 10.1186/s40560-014-0055-2. eCollection 2014.
5
Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.多粘菌素B固定化纤维柱血液灌流在整个24小时治疗期间均可清除内毒素。
J Crit Care. 2014 Oct;29(5):728-32. doi: 10.1016/j.jcrc.2014.03.031. Epub 2014 Apr 4.
6
Efficacy of endotoxin adsorption therapy (polymyxin B hemoperfusion) for methicillin-resistant Staphylococcus aureus toxic shock syndrome: a case report about five patients.多黏菌素 B 血液灌流治疗耐甲氧西林金黄色葡萄球菌中毒性休克综合征的疗效:5 例病例报告。
Minerva Anestesiol. 2013 Jul;79(7):758-61. Epub 2013 May 2.
7
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南:2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
8
Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.早期应用多粘菌素B血液灌流治疗腹部感染性休克:EUPHAS随机对照试验
JAMA. 2009 Jun 17;301(23):2445-52. doi: 10.1001/jama.2009.856.
9
A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.更长时间的多黏菌素 B 固定纤维柱血液灌流可改善感染性休克患者的肺氧合。
Shock. 2009 Nov;32(5):478-83. doi: 10.1097/SHK.0b013e3181a2a978.
10
Specific Removal of Monocytes from Peripheral Blood of Septic Patients by Polymyxin B-immobilized Filter Column.用多粘菌素B固定化滤柱特异性去除脓毒症患者外周血中的单核细胞。
Acta Med Okayama. 2009 Feb;63(1):65-9. doi: 10.18926/AMO/31855.